Results for “”

Entry Author Date Location
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline 06/04/20 Boston
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
Early Bird Sale Ends Friday, June 5 for Xconomy’s AI & Drug Discovery Online Forum and Networking Conference 06/04/20 National
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Grail Plants a Seed in RTP, Pledges $100M Investment in New Site 06/02/20 Raleigh Durham
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech 06/02/20 Seattle
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds 05/29/20 National
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs 05/28/20 Seattle
FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies 05/28/20 National
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact 05/27/20 San Francisco
Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations 05/27/20 New York
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
COVID-19 Sparks New Opportunities for Digital Health Companies 05/26/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
FDA Approves Evofem’s “On-Demand” Non-Hormonal Birth Control Gel 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment 05/22/20 Boston
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes 05/21/20 Boston
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
Vividion Gets $135M in Collaboration With Roche on Protein Degradation 05/20/20 San Diego
Page 1 of 1967 next page »